Presentation

0 Comments

9 January 2017

ISAR-REACT 4

Dr Will Orr

Discussion of the ISAR-REACT-4 trial

Previous | Next
Download

Summary

Trial vignette of the ISAR-REACT-4 study: a randomised double blind trial of abciximab + unfractionated heparin vs bivalirudin in NSTEMI, published in the New England Journal of Medicine.

Download

Summary

Trial vignette of the ISAR-REACT-4 study: a randomised double blind trial of abciximab + unfractionated heparin vs bivalirudin in NSTEMI, published in the New England Journal of Medicine.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In